KNOWLEDGE CENTER · Peptide Fundamentals
Essential Terminology in Peptide Research
Plain definitions for reading peptide specifications: identity, sequence, molecular mass, purity, content, freeze-drying and lot traceability.
Published by THAI BIO LABSSelected sources checked: · AI-assisted screening; specialist review pending
Article contents
CORE ANSWER
A peptide specification uses different measurements to answer different questions: what is the material, what does its purity result show and how much target material is present?
Identity, molecular mass, chromatographic purity, content and lot traceability each describe part of the record. No single number replaces the full analytical record.
Sequence, identity and molecular mass
The amino-acid sequence is the precise order of residues in a peptide. Molecular mass is the mass expected from that sequence and any specified chemical modifications.
Mass spectrometry can support identity by comparing measured mass-to-charge information with the mass expected for the target molecule. [1]
Purity and peptide content
Chromatographic purity reports the relative detector signal attributed to the target peak under the stated method. It is not automatically the mass fraction of the target material. Peptide content is a separate measurement whose method and reporting basis should be specified. [2]
A vial can therefore have a high chromatographic purity result while peptide content, total fill quantity or molecular identity remains a separate question.
Freeze-dried material and reconstitution
Lyophilised means that water has been removed from a frozen material under reduced pressure. Reconstitution is the controlled addition of a suitable laboratory diluent to return that dry material to solution. [3]
These terms describe physical state and handling. They do not establish identity, purity, sterility or clinical suitability.
Batch, lot, COA and traceability
A batch or lot number connects a physical material to its production and analytical records. A Certificate of Analysis (COA) summarises specified tests and results for a sample or lot.
- Lot or batch identifier
- Sample identity
- Laboratory or testing source
- Analytical method
- Test date
- Specification and reported result
Traceability depends on those elements linking coherently. A generic report with no meaningful connection to the physical lot provides weaker documentation than a lot-specific record.
KEY PRINCIPLE
Identity, purity, content and traceability are separate analytical concepts. Strong documentation makes those distinctions visible.
TECHNICAL REFERENCES
Standards and source material
Numbered markers link specific technical statements to the sources below. Other practical guidance is TBL editorial interpretation. These references do not certify a TBL lot, method or shelf life.
Separation according to mass-to-charge ratio; not proof of a particular sample identity.FDA / ICH Q2(R2), 2024 — analytical validation
Selectivity, accuracy and calibration; sections 3.1–3.3 and assay examples.FDA — Lyophilization of Parenteral (1993)
Process and control context from an older pharmaceutical inspection guide; not a handling protocol.FDA / ICH Q7, 2016 — sampling and certificates
Representative sampling: 7.3. Certificate fields: 11.4. Context, not a TBL GMP certification.
Batch Records
Read the lot-documentation guidance
Open THAI BIO LABS Batch Records for guidance on identifiers, methods and results. Genuine lot records will be published when supporting documents are ready for review.
Open Batch RecordsRESEARCH-USE BOUNDARY
For research use only. Not for human or veterinary use.
THAI BIO LABS Knowledge Center content explains scientific terminology, analytical methods, documentation and laboratory-handling concepts. It does not provide medical advice, treatment protocols, dosing or administration instructions.
